INFUSE BONE GRAFT
Report
- Report Number
- 1030489-2014-03821
- Event Type
- Injury
- Date Received
- October 6, 2014
- Report Date
- August 29, 2016
- Manufacturer
- MEDTRONIC SOFAMOR DANEK USA, INC
- Product Code
- NEK
- PMA / PMN Number
- P000058
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- MO, US
- Reporter Occupation
- ATTORNEY
Narratives
A GOOD FAITH EFFORT WILL BE MADE TO OBTAIN THE APPLICABLE INFORMATION RELEVANT TO THE REPORT. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.
(B)(4). NEITHER THE DEVICE NOR FILMS OF APPLICABLE IMAGING STUDIES WERE RETURNED TO THE MANUFACTURER FOR EVALUATION. THEREFORE, WE ARE UNABLE TO DETERMINE THE DEFINITIVE CAUSE OF THE REPORTED EVENT. PRODUCTS FROM MULTIPLE MANUFACTURERS WERE IMPLANTED DURING THE PROCEDURE. ALTHOUGH IT IS UNKNOWN IF ANY OF THE DEVICES CONTRIBUTED TO THE REPORTED EVENT, WE ARE FILING THIS MDR FOR NOTIFICATION PURPOSES.
IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.
IT WAS REPORTED THAT THE PATIENT UNDERWENT A TRANSFORAMINAL AND POSTERIOR LUMBAR FUSION AT L5-S1 USING RHBMP-2/ACS COMBINED WITH AUTOGRAFT, PLACED INSIDE OF A SPINAL ELEMENTS LUCENT VBR CAGE. FOLLOWING THE SURGERY, THE PATIENT HAD CONTINUED BACK AND LEG PAIN. THE PATIENT UNDERWENT ADDITIONAL IMAGING. A CT SCAN DATED (B)(6) 2009 DEMONSTRATED THAT THE PATIENT HAD DEVELOPED ECTOPIC BONE GROWTH. THE PATIENT REQUIRED AN ADDITIONAL SURGERY TO REMOVE HARDWARE AND REMOVE ECTOPIC BONE GROWTH ON (B)(6) 2009. THE PATIENT HAS NEVER RECOVERED FROM HIS SURGERY, AND HE HAS DAILY, DISABLING PAIN THAT PREVENTS HIM FROM PERFORMING MANY BASIC ACTIVITIES OF DAILY LIVING.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 622209 | INFUSE BONE GRAFT | FILLER, RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN, COLLAGEN SCAFFOLD WITH MET | NEK | MEDTRONIC SOFAMOR DANEK USA, INC | NA | M110607AAE |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 31 YR | Required Intervention |